Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Stephens & Co. Maintains Equal-Weight on Veradigm, Raises Price Target to $13

Author: Benzinga Newsdesk | January 31, 2025 11:38am
Stephens & Co. analyst Jeff Garro maintains Veradigm (OTC:MDRX) with a Equal-Weight and raises the price target from $7 to $13.

Posted In: MDRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist